Tag: Ulcerative Colitis
FDA: Blood Clot, Death Risk Up With Higher Dose of Tofacitinib
Increased risk seen with 10 mg dose of tofacitinib used for treating ulcerative colitis
Infliximab Introduction Has Not Cut IBD-Related Hospitalizations
Introduction of infliximab did not lead to drop in hospitalization, intestinal resection, colectomy
Biomarker Test Predicts Mild, Serious IBD in Newly Diagnosed
Test based on genetic signature of CD8 T cells during active disease
In Men, Low BMI Tied to Later Inflammatory Bowel Disease
Risk lasts through 40 years of adulthood for underweight adolescent men
Recommendations Developed for Ulcerative Colitis Management
Guidelines address diagnosis, treatment, and overall clinical management of adult patients
Patient, Doctor Communication Priorities Differ in Ulcerative Colitis
Second study highlights importance of recognizing the emotional impact of ulcerative colitis
Guideline Issued for Treatment of Mild/Moderate Ulcerative Colitis
Standard-dose mesalamine or diazo-bonded 5-ASA recommended versus low-dose mesalamine
Psoriasis Linked to Increased Risk for Inflammatory Bowel Disease
Significant associations observed between psoriasis and risk for Crohn's disease, ulcerative colitis
Loss to Follow-Up Common With IBD, But Many Have Flare-Ups
Predictors of follow-up loss are long travel time and low C-reactive protein levels at diagnosis
FDA Approves New Treatment for Ulcerative Colitis
First oral medication approved for chronic use in moderate-to-severe active ulcerative colitis
